dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination has been researched along with Pneumothorax, Primary Spontaneous in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auten, RL; Balsan, MJ; Belcastro, MR; Brody, AS; Buckwald, S; Carrion, V; Donohue, PK; Durand, DJ; Egan, EA; Farrell, EE; Graeber, JE; Horgan, MJ; Hudak, ML; Jansen, RD; Jung, AL; Laskay, KM; Maniscalco, WW; Martin, DJ; Matteson, EJ; Miller, RR; Montgomery, P; Riddlesberger, MM; Rosenberg, AA; Torres, BA | 1 |
1 trial(s) available for dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and Pneumothorax, Primary Spontaneous
| Article | Year |
|---|---|
A multicenter randomized, masked comparison trial of natural versus synthetic surfactant for the treatment of respiratory distress syndrome.
Topics: Bronchopulmonary Dysplasia; Cross-Over Studies; Drug Combinations; Fatty Alcohols; Humans; Incidence; Infant, Newborn; Length of Stay; Linear Models; Phosphorylcholine; Pneumothorax; Polyethylene Glycols; Pulmonary Emphysema; Pulmonary Surfactants; Respiration, Artificial; Respiratory Distress Syndrome, Newborn; Survival Rate; Time Factors; Treatment Outcome | 1996 |